Schedule of Stock Options Roll Forward (Details) - Equity Option [Member] - USD ($) $ / shares in Units, $ in Thousands |
9 Months Ended | |||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
Sep. 30, 2023 |
Sep. 30, 2022 |
|||||||||||
Debt Securities, Held-to-Maturity, Allowance for Credit Loss [Line Items] | ||||||||||||
Shares Options Outstanding Beginning | 1,018,400 | 1,019,400 | ||||||||||
Weighted Average Exercise Price Options Outstanding Beginning | $ 5.02 | $ 4.91 | ||||||||||
Aggregate Intrinsic Value Options Exercisable | [1] | [2] | ||||||||||
Shares, Granted | 365,000 | 94,000 | ||||||||||
Weighted Average Exercise Price, Granted | $ 3.19 | $ 5.20 | ||||||||||
Shares, Exercised | (282,400) | (52,400) | ||||||||||
Weighted Average Exercise Price, Exercised | $ 3.70 | $ 4.04 | ||||||||||
Aggregate Intrinsic Value, Exercised | $ 2,118,892 | [1] | $ 97,856 | [2] | ||||||||
Shares, Forfeited/expired | (64,500) | (9,600) | ||||||||||
Weighted Average Exercise Price, Forfeited/expired | $ 3.67 | $ 5.50 | ||||||||||
Shares Options Outstanding Ending | 1,036,500 | [3] | 1,051,400 | [4] | ||||||||
Weighted Average Exercise Price Options Outstanding Ending | $ 5.48 | [3] | $ 4.98 | [4] | ||||||||
Weighted Average Remaining Contractual Term (years) Outstanding | 5 years 1 month 6 days | [3] | 4 years | [4] | ||||||||
Aggregate Intrinsic Value, Options outstanding end of period | $ 5,146,126 | [1],[3] | $ 492,939 | [2],[4] | ||||||||
Shares, Options exercisable | 302,300 | [1] | 453,900 | [4] | ||||||||
Weighted Average Exercise Price, Options exercisable | $ 4.91 | [1] | $ 3.93 | [4] | ||||||||
Weighted Average Remaining Contractual Term (years) Exercisable | 3 years 10 months 24 days | [1] | 2 years 4 months 24 days | [4] | ||||||||
Aggregate Intrinsic Value Options Exercisable | $ 1,675,604 | [1] | $ 354,709 | [2],[4] | ||||||||
|
X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
X | ||||||||||
- Definition The number of shares into which fully or partially vested stock options outstanding as of the balance sheet date can be currently converted under the option plan. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
X | ||||||||||
- Definition The weighted-average price as of the balance sheet date at which grantees can acquire the shares reserved for issuance on vested portions of options outstanding and currently exercisable under the stock option plan. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
X | ||||||||||
- Definition Amount of accumulated difference between fair value of underlying shares on dates of exercise and exercise price on options exercised (or share units converted) into shares. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
X | ||||||||||
- Definition For presentations that combine terminations, the number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan or that expired. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
X | ||||||||||
- Definition Weighted average price of options that were either forfeited or expired. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
X | ||||||||||
- Definition Gross number of share options (or share units) granted during the period. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
X | ||||||||||
- Definition Amount by which the current fair value of the underlying stock exceeds the exercise price of options outstanding. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition Number of options outstanding, including both vested and non-vested options. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
X | ||||||||||
- Definition Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
X | ||||||||||
- Definition Weighted average price at which option holders acquired shares when converting their stock options into shares. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
X | ||||||||||
- Definition Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
X | ||||||||||
- Definition Amount of difference between fair value of the underlying shares reserved for issuance and exercise price of vested portions of options outstanding and currently exercisable. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition Weighted average remaining contractual term for vested portions of options outstanding and currently exercisable or convertible, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition Weighted average remaining contractual term for option awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition Number of share options (or share units) exercised during the current period. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Details
|